Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
Bevacizumab is a recombinant humanized monoclonal antibody and a key drug for treatment of various types of cancer. Bevacizumab is associated with the occurrence of heart failure, but its risk factors remain unknown. A 55-year-old woman was diagnosed with cervical cancer, which was completely treate...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2021-09-01
|
| Серія: | Medicina |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1648-9144/57/10/998 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|